Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Function Impairment in Healthy Volunteers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01730469
What this trial is testing

Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function

Who this might be right for
Fabry Disease
Amicus Therapeutics 32
Early research (Phase 1)Study completedNCT01240967
What this trial is testing

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Who this might be right for
Healthy VolunteersPatientsPharmacokinetics+1 more
AstraZeneca 40
Early research (Phase 1)Study completedNCT05495581
What this trial is testing

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 28
Early research (Phase 1)Study completedNCT06698549
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

Who this might be right for
COVID 19
Aligos Therapeutics 12
Early research (Phase 1)Not Yet RecruitingNCT07797322
What this trial is testing

Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Who this might be right for
Participants With Moderate and Severe Renal Impairment and Healthy Participants
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT05515432
What this trial is testing

Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

Who this might be right for
Chronic Kidney DiseaseRenal ImpairmentHealthy Volunteers
Bayer 45
Testing effectiveness (Phase 2)Study completedNCT01569828
What this trial is testing

Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Who this might be right for
PharmacokineticsRenal ImpairedHealthy Volunteer
Novartis Pharmaceuticals 12
Early research (Phase 1)Looking for participantsNCT07694869
What this trial is testing

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function

Who this might be right for
Healthy ParticipantsParticipants With Moderate Renal Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 16
Early research (Phase 1)Looking for participantsNCT07315360
What this trial is testing

Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

Who this might be right for
Renal ImpairmentHealthy
Pfizer 28
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Early research (Phase 1)Study completedNCT04908436
What this trial is testing

Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureChronic Kidney Disease
Bayer 33
Early research (Phase 1)Study completedNCT03161015
What this trial is testing

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Global Blood Therapeutics 16
Early research (Phase 1)Study completedNCT04909853
What this trial is testing

Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.

Who this might be right for
Renal Impairment
Pfizer 35
Early research (Phase 1)Study completedNCT03172884
What this trial is testing

Study of Copanlisib in Hepatic or Renal Impairment

Who this might be right for
Hepatic Insufficiency, Renal Insufficiency
Bayer 30
Early research (Phase 1)Ended earlyNCT04037865
What this trial is testing

A Renal Impairment Study for PF-06651600

Who this might be right for
Renal Impairment
Pfizer 8
Early research (Phase 1)Ended earlyNCT00721422
What this trial is testing

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Who this might be right for
Renal InsufficiencyPharmacokinetics
Pfizer 16
Early research (Phase 1)Study completedNCT02340195
What this trial is testing

Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 16
Early research (Phase 1)Study completedNCT03890770
What this trial is testing

Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

Who this might be right for
Renal ImpairmentHealthy Volunteer
Bristol-Myers Squibb 44
Early research (Phase 1)Study completedNCT05032235
What this trial is testing

Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Renal Impairment
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)UnknownNCT04414852
What this trial is testing

Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function

Who this might be right for
Subjects With Impaired Renal Function and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd. 24
Next Page